A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus
Clinical trial NCT03421379 · COMPLETED
Trial details
- NCT number
- NCT03421379
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2018-08-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.